Association between pre‐operative sodium‐glucose cotransporter‐2 inhibitor use and postoperative outcomes: a propensity score‐matched analysis of the TriNetX database

Our study showed a significantly reduced risk of postoperative mortality and morbidity associated with pre-operative sodium-glucose cotransporter-2 inhibitor use in patients with type 2 diabetes mellitus, including a notably lower rate of diabetic ketoacidosis, contrary to previous concerns. Randomised controlled trials are warranted to validate these findings.